The World Health Summit brings together leading researchers, physicians, government officials and representatives from industry, non-governmental organizations (NGOs) and health care systems worldwide.
Among the confirmed speakers are:
(in alphabetical order)
After graduating from Medicine in Alexandria, he practiced medicine in Scotland and obtained his postgraduate training and qualifications in the UK. Following his return to Iraq he held several positions in clinical and academic medicine and public health. He was Professor and Dean of the Faculty of Medicine, Mustansiriya University, Baghdad, and used to serve as WHO Assistant Director-General for Noncommunicable Diseases and Mental Health.
After studying economics he joined Bayer in the Corporate Finance Department. He held several international positions in the company, including member of the Executive Committee and Head of Central Administration & Organization at Bayer HealthCare and Chief Financial Officer of Bayer AG.
Formally the Senior Vice President and CFO for Philips Home Healthcare Solutions, he joined Philips from Baxter Healthcare, where he acted as the European Regional Controller. He accumulated more than 20 years of experience in the healthcare industry, recently completing about 25 M&A transactions with a particular focus on targets in the areas of Home Healthcare, Clinical Decision Support, Imaging and Image Guided Intervention and Treatment.
He was previously the Parliamentary Under Secretary of State at the Department of Health, where he was responsible for social services and mental health. Within this role he published guidelines to end the denial of adoptions purely on the basis of race.
An accomplished Corneal Surgeon and Ophthalmologist, Hélène Boisjoly is the first woman to hold the position of Dean of Faculty of Medicine at the University of Montreal and within the greater province of Quebec. She is the International President of the World Health Summit 2017.
After completing his medical studies in Germany, the specialist for personalized medicine moved to the U.S., where he conducted research at several institutions, among them Massachusetts General Hospital, Harvard Medical School and the National Cancer Institute in Bethesda. He has been the Director of the Biotechnology Center at Albert Einstein College of Medicine in New York, and Director of the Charles Bronfman Institute for Personalized Medicine.
The Professor of infectious diseases and bacteriology used to be Executive Director of the Roll Back Malaria Partnership, served as Director of the UNAIDS Department of Country and Regional Support and was Minister of Health and Prevention of Senegal. She has been awarded numerous professional and academic honours.
Previously a Senior Health Policy Analyst in the Health Division, she is now responsible for OECD work on health which aims at providing internationally comparable data on health systems and applying economic analysis to health policies, in this way advising policy makers, stakeholders and citizens on how to respond to healthcare demands.
Working for the NCD Alliance since its founding in 2009, she holds experience in organizational and strategic development, global advocacy and policy-making, program design as well as capacity-building in low- and middle-income countries. Before joining the NCD Alliance, she worked at the International Diabetes Federation (IDF) in Brussels, leading their global advocacy program and establishing the first Women and Diabetes program.
She held the Swiss Federal Department of Home Affairs, was the first woman ever to be elected President of the Confederation and won several referendums, including a revision of the Health Insurance Bill, the 10th revision of the social security system, and a drug policy based on prevention, therapy, help and rehabilitation. She is a member of the Council of Women World Leaders.
She graduated with degrees from the University of the West Indies in Jamaica and the London School of Hygiene & Tropical Medicine, UK, was the Director of Primary Health Care Services, Disaster Coordinator, a National Epidemiologist in the Ministry of Health, Coordinator of the National AIDS Program, Chair of the National AIDS Committee and undertook two separate terms as Chief Medical Officer. She was the Assistant Director of PAHO, served as the Assistant Director-General of Health Systems and Services at the WHO and was elected PAHO director in September 2012.
A professor of Public Health at University Descartes, Sorbonne Paris Cité, he is chair of the Centre Virchow Villermé de Santé Publique Paris-Berlin, co-chairs the European Academic Global Health Alliance, is president of the European Agency for Public Health Education Accreditation and Founding Director of the Institute of Global Health, University of Geneva. In 2016, Antoine Flahault was the International President of the World Health Summit.
With an impressive track record as a business executive - most recently as CEO of Lufthansa - and an exceptional global network, he has been a member of the Roche board since 2011 and was elected as Chair in 2014.
A specialist in pharmacology and molecular medicine, Detlev Ganten is one of the world’s top scientists in the field of hypertension. He is the Founding President of the World Health Summit, a former CEO of the Charité – Universitätsmedizin Berlin and Founding Director and CEO of the Max Delbrück Center for Molecular Medicine.
Since 2004, Laurie Garrett has been a senior fellow for global health at the Council on Foreign Relations in New York. Garrett is the only writer ever to have been awarded all three of the Big "Ps" of journalism: the Peabody, the Polk, and the Pulitzer. Her expertise includes global health systems, chronic and infectious diseases, and bioterrorism.
Hermann Gröhe is a certified lawyer who has held a seat in the German Bundestag since 1994. He was a spokesperson for human rights and humanitarian assistance in the Bundestag and acted as legal counsel to the CDU/CSU parliamentary group. Gröhe served one year as a Minister of State to the Federal Chancellor, was the CDU Secretary-General and was appointed Federal Minister of Health in 2013.
An Infectious Disease Epidemiologist and consultant in Public Health Medicine, he used to be the Managing Partner at EpiAfric, worked as co-Director of the Centre for Tuberculosis at the South African National Institute for Communicable Diseases, and was a Consultant Medical Epidemiologist with the UK's Health Protection Agency and at Germany’s Robert Koch Institute. His scientific research has been focused largely on intervention epidemiology.
Ambassador Wolfgang Ischinger began his highly successful diplomatic career in 1973 in the cabinet of the UN Secretary-General. In 1998, he was appointed State Secretary (Deputy Foreign Minister) of the Foreign Office. He has been chairman of the Munich Security Conference since 2008.
He is Professor Emeritus of Global Health at the University of California, San Francisco, as well as at the University of Washington, Seattle. He served as the T. & G. Angelopoulos Visiting Professor of Public Health and International Development in the Harvard Kennedy School and the Harvard School of Public Health. Previously, he has worked at the University of California, Los Angeles, and held the position of Director of the World Development Report Office at the World Bank.
After holding several positions including Staff Scientist at the Max Planck Institute for Immunobiology in Freiburg and Chair of the Department of Immunology at the University of Ulm, he became the Founding Director of the Max Planck Institute for Infection Biology in Berlin. The Microbiology and Immunology expert is a member of the Berlin-Brandenburg Academy of Sciences and Humanities (BBAW) and the German National Academy of Sciences Leopoldina.
As a leading contributor to academic and political debates on governance for health at a national and global level, she conducts global health diplomacy seminars in many regions and advises the World Health Organization (WHO). In Switzerland, she serves on the executive board of the Careum Foundation and as an advisor for Health 2020.
A world renowned kidney disease epidemiologist, his scientific contributions have aided in the prevention and epidemiology of kidney disease, hypertension and cardiovascular disease. He led pioneering studies in kidney disease epidemiology, including the first study to assess the incidence of end-stage renal disease and to identify blood pressure as a risk factor for the development of kidney failure.
An anthropologist and expert for infectious disease epidemiology, she headed the Global Immunisation Communication at UNICEF, chaired GAVI’s Advocacy Task Force, and served on the WHO SAGE Working Group on vaccine hesitancy. Her research focuses on the analysis of social and political factors that can affect uptake of health interventions and influence policies. Her particular interest is on risk and rumor management from clinical trials to delivery as well as building public trust.
He brings expertise in global revenue management, product innovation, corporate strategy, organizational and mergers, as well as acquisition to his role at SAP. Previously, he served as CEO of Sutherland Healthcare Solutions and worked at Cognizant as the Managing Director of the Healthcare Innovation Digital Ventures and Global Director of Strategy.
Trained at McGill University School of Medicine and specialized in pediatrics at Montreal’s Sainte-Justine hospital, she holds a fellowship in pediatric emergency medicine from New York University School of Medicine, and an International Master’s in Health Leadership from McGill University. She is also an associate professor at the University of Montreal and a professor in practice at McGill University. She has worked in many conflict zones, including in Palestine, Central African Republic, DRC and Sudan’s Darfur region.